Diagnamed Holdings (XCNQ:DMED) Interest Expense : C$-0.05 Mil (TTM As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Diagnamed Holdings Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Diagnamed Holdings's interest expense for the three months ended in Dec. 2024 was C$ 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was C$-0.05 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Diagnamed Holdings's Operating Income for the three months ended in Dec. 2024 was C$ -0.11 Mil. Diagnamed Holdings's Interest Expense for the three months ended in Dec. 2024 was C$ 0.00 Mil. Diagnamed Holdings has no long-term debt ⁽¹⁾. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Diagnamed Holdings Interest Expense Historical Data

The historical data trend for Diagnamed Holdings's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diagnamed Holdings Interest Expense Chart

Diagnamed Holdings Annual Data

Trend

Sep21

Sep22

Sep23

Sep24

Interest Expense

Diagnamed Holdings Quarterly Data
	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Interest Expense	Get a 7-Day Free Trial									-	-	-0.05	-	-

Diagnamed Holdings Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.05 Mil.

Diagnamed Holdings (XCNQ:DMED) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Diagnamed Holdings's Interest Expense for the three months ended in Dec. 2024 was C$0.00 Mil. Its Operating Income for the three months ended in Dec. 2024 was C$-0.11 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2024 was C$0.00 Mil.

Diagnamed Holdings's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Diagnamed Holdings had no long-term debt ⁽¹⁾.

The higher the ratio, the stronger the company's financial strength is.

Diagnamed Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Diagnamed Holdings Corp (XCNQ:DMED) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

DGNMF:USA

Address

82 Richmond Street East, Toronto, ON, CAN, M5C 1P1

Website

https://www.diagnamed.com

Diagnamed Holdings Corp is engaged in developing a platform of software-based prescription digital therapeutic products (PDT Products) with the potential to improve early detection of neurological disorders, overall patient health and lower healthcare costs. Its products include, CERVAI which is a brain health AI platform leveraging that aims to predict and monitor brain age and provide actionable insights for mental health and neurodegenerative disorders. It is also investigating other technological applications such as BrainAge and BrainTremor.

Executives

Fabio Chianelli

Director, Senior Officer

Diagnamed Holdings Headlines

No Headlines